No Data
No Data
Form 144 | Belite Bio(BLTE.US) Insider Proposes to Sell 641.25K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Belite Bio(BLTE.US)$ Insider Nathan Mata intends to sell 15,000 shares of its common stock on May 20, with a total market value of approximately $641.25K. Nathan Mat
Form 144 | Belite Bio(BLTE.US) Insider Proposes to Sell 1.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Belite Bio(BLTE.US)$ Insider Ching Chen Chiu intends to sell 35,000 shares of its common stock on May 16, with a total market value of approximately $1.49 million.
Buy Rating Affirmed for Belite Bio, Inc. on Strong Clinical Trials and Solid Financial Footing
Express News | Benchmark Reiterates Buy on Belite Bio, Maintains $57 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), CareCloud (CCLD)
Buy Rating Affirmed for Belite Bio, Inc. ADR on Strong Financials and Promising Stargardt Disease Drug Prospects
No Data